166 related articles for article (PubMed ID: 8200229)
1. Relationship among p53, stage, and prognosis of large bowel cancer.
Nathanson SD; Linden MD; Tender P; Zarbo RJ; Jacobsen G; Nelson LT
Dis Colon Rectum; 1994 Jun; 37(6):527-34. PubMed ID: 8200229
[TBL] [Abstract][Full Text] [Related]
2. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location.
Gervaz P; Bouzourene H; Cerottini JP; Chaubert P; Benhattar J; Secic M; Wexner S; Givel JC; Belin B
Dis Colon Rectum; 2001 Mar; 44(3):364-72; discussion 372-3. PubMed ID: 11289282
[TBL] [Abstract][Full Text] [Related]
3. Correlation of p53 with the clinicopathologic features and prognosis of colorectal adenocarcinoma.
Suzuki H; Matsumoto K; Koide A; Tada T; Fujino I; Okuda A; Shigemori C
Surg Today; 1994; 24(1):85-7. PubMed ID: 8054784
[TBL] [Abstract][Full Text] [Related]
4. Cyclin E, p27 and mutant p53 do not predict the prognosis in AJCC stage II colorectal carcinomas.
Lim YJ; Kim YH; Ahn GH; Chun HK; Jang WY; Lee JH; Son HJ; Rhee PL; Kim JJ; Paik SW; Yoo BC; Rhee JC
Korean J Gastroenterol; 2004 Dec; 44(6):314-20. PubMed ID: 15665575
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.
Thor AD; Moore DH II; Edgerton SM; Kawasaki ES; Reihsaus E; Lynch HT; Marcus JN; Schwartz L; Chen LC; Mayall BH
J Natl Cancer Inst; 1992 Jun; 84(11):845-55. PubMed ID: 1317462
[TBL] [Abstract][Full Text] [Related]
6. Clinico-pathological correlation and prognostic significance of nuclear p53 protein in colorectal cancer. Colorectal Cancer Study Group of the University and Health Care District of Modena.
Fante R; Di Gregorio C; Losi L; Roncucci L; Ponz de Leon M
Ital J Gastroenterol; 1996 May; 28(4):205-10. PubMed ID: 8842835
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.
Bosari S; Viale G; Bossi P; Maggioni M; Coggi G; Murray JJ; Lee AK
J Natl Cancer Inst; 1994 May; 86(9):681-7. PubMed ID: 8158699
[TBL] [Abstract][Full Text] [Related]
8. Combination of p53 expression and p21 loss has an independent prognostic impact on sporadic colorectal cancer.
Noske A; Lipka S; Budczies J; Müller K; Loddenkemper C; Buhr HJ; Kruschewski M
Oncol Rep; 2009 Jul; 22(1):3-9. PubMed ID: 19513497
[TBL] [Abstract][Full Text] [Related]
9. Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1).
Grizzle WE; Manne U; Weiss HL; Jhala N; Talley L
Int J Cancer; 2002 Feb; 97(4):403-9. PubMed ID: 11802199
[TBL] [Abstract][Full Text] [Related]
10. p53 accumulation associated with bcl-2, the proliferation marker MIB-1 and survival in patients with prostate cancer subjected to watchful waiting.
Borre M; Stausbol-Gron B; Overgaard J
J Urol; 2000 Sep; 164(3 Pt 1):716-21. PubMed ID: 10953132
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the correlation between p53 and bcl-2 expression with staging and prognosis of the colorectal adenocarcinoma.
Lustosa SA; Logullo A; Artigiani R; Saad SS; Goldenberg A; Matos D
Acta Cir Bras; 2005; 20(5):353-7. PubMed ID: 16186958
[TBL] [Abstract][Full Text] [Related]
12. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI
Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268
[TBL] [Abstract][Full Text] [Related]
13. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas.
Diez M; Medrano M; Mugüerza JM; Ramos P; Hernandez P; Villeta R; Martín A; Noguerales F; Ruiz A; Granell J
Anticancer Res; 2000; 20(5C):3907-12. PubMed ID: 11268475
[TBL] [Abstract][Full Text] [Related]
14. [Variation in the prognostic value of p53 protein in relation to tumoral stage in patients with colorectal adenocarcinoma].
Díez M; Pollán M; Ramos P; Villeta R; Ratia T; Hernández P; Lozano O; Noguerales F; Granell J
Cir Esp; 2005 Apr; 77(4):213-20. PubMed ID: 16420920
[TBL] [Abstract][Full Text] [Related]
15. p53 accumulation confers prognostic information in resectable adenocarcinomas with ductal but not with intestinal differentiation in the pancreatic head.
Bergan A; Gladhaug IP; Schjolberg A; Bergan AB; Clausen OP
Int J Oncol; 2000 Nov; 17(5):921-6. PubMed ID: 11029493
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma.
Zhang Hong
Clin Cancer Res; 1999 Dec; 5(12):4126-32. PubMed ID: 10632350
[TBL] [Abstract][Full Text] [Related]
17. [P53 protein in adenocarcinoma of the large intestine].
Paluszkiewicz P; Pawłowska-Wakowicz B; Cybulski M; Berbeć H
Wiad Lek; 1997; 50 Suppl 1 Pt 1():87-91. PubMed ID: 9446410
[TBL] [Abstract][Full Text] [Related]
18. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
[TBL] [Abstract][Full Text] [Related]
19. Mutant p53 protein as a predictor of survival in endometrial carcinoma.
Strang P; Nordstöm B; Nilsson S; Bergström R; Tribukait B
Eur J Cancer; 1996 Apr; 32A(4):598-602. PubMed ID: 8695259
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer.
Williams DS; Mouradov D; Browne C; Palmieri M; Elliott MJ; Nightingale R; Fang CG; Li R; Mariadason JM; Faragher I; Jones IT; Churilov L; Tebbutt NC; Gibbs P; Sieber OM
Mod Pathol; 2020 Mar; 33(3):483-495. PubMed ID: 31471586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
